These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 10652791)

  • 1. [Molecular modeling studies of prolyl endopeptidase inhibitors].
    Kánai K; Fehér M; Lopata A; Podányi B; Novák I; Susán E; Hermecz I; Arányi P
    Acta Pharm Hung; 1999 Nov; 69(5):240-6. PubMed ID: 10652791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prolyl endopeptidase inhibitors].
    Aoyagi T; Muraoka Y
    Tanpakushitsu Kakusan Koso; 1993 Aug; 38(11):1971-86. PubMed ID: 8210438
    [No Abstract]   [Full Text] [Related]  

  • 3. An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitors.
    Nicolotti O; Miscioscia TF; Carotti A; Leonetti F; Carotti A
    J Chem Inf Model; 2008 Jun; 48(6):1211-26. PubMed ID: 18540590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel inhibitors of prolyl endopeptidase: effects of stereochemistry.
    Kolosko N; Bakker AV; Faraci WS; Nagel AA
    Drug Des Discov; 1994 Jan; 11(1):61-71. PubMed ID: 8068820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suggested functions for prolyl oligopeptidase: a puzzling paradox.
    Brandt I; Scharpé S; Lambeir AM
    Clin Chim Acta; 2007 Feb; 377(1-2):50-61. PubMed ID: 17034776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of prolyl endopeptidase: characterization of the pharmacophoric pattern using conformational analysis and 3D-QSAR.
    Langer T; Wermuth CG
    J Comput Aided Mol Des; 1993 Jun; 7(3):253-62. PubMed ID: 8377023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
    Bhongade BA; Gouripur VV; Gadad AK
    Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrrolidinyl pyridone and pyrazinone analogues as potent inhibitors of prolyl oligopeptidase (POP).
    Haffner CD; Diaz CJ; Miller AB; Reid RA; Madauss KP; Hassell A; Hanlon MH; Porter DJ; Becherer JD; Carter LH
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4360-3. PubMed ID: 18606544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cyclopent-2-enecarbonyl group mimics proline at the P2 position of prolyl oligopeptidase inhibitors.
    Jarho EM; Venäläinen JI; Huuskonen J; Christiaans JA; Garcia-Horsman JA; Forsberg MM; Järvinen T; Gynther J; Männistö PT; Wallén EA
    J Med Chem; 2004 Nov; 47(23):5605-7. PubMed ID: 15509157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitors of serine proteases as potential therapeutic agents: the road from thrombin to tryptase to cathepsin G.
    Maryanoff BE
    J Med Chem; 2004 Feb; 47(4):769-87. PubMed ID: 14761180
    [No Abstract]   [Full Text] [Related]  

  • 11. The relationship between inhibitors of eukaryotic and prokaryotic serine proteases.
    Konaklieva MI; Plotkin BJ
    Mini Rev Med Chem; 2004 Sep; 4(7):721-39. PubMed ID: 15379640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of inhibitors of NS3 serine protease of hepatitis C virus.
    Frecer V; Kabelác M; De Nardi P; Pricl S; Miertus S
    J Mol Graph Model; 2004 Jan; 22(3):209-20. PubMed ID: 14629979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulfated chitooligosaccharides as prolyl endopeptidase inhibitor.
    Je JY; Kim EK; Ahn CB; Moon SH; Jeon BT; Kim B; Park TK; Park PJ
    Int J Biol Macromol; 2007 Dec; 41(5):529-33. PubMed ID: 17714777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules.
    Kánai K; Arányi P; Böcskei Z; Ferenczy G; Harmat V; Simon K; Bátori S; Náray-Szabo G; Hermecz I
    J Med Chem; 2008 Dec; 51(23):7514-22. PubMed ID: 19006380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-phase synthesis and SAR of 4-carboxy-2-azetidinone mechanism-based tryptase inhibitors.
    Sutton JC; Bolton SA; Davis ME; Hartl KS; Jacobson B; Mathur A; Ogletree ML; Slusarchyk WA; Zahler R; Seiler SM; Bisacchi GS
    Bioorg Med Chem Lett; 2004 May; 14(9):2233-9. PubMed ID: 15081015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzimidazolium salts as small, nonpeptidic and BBB-permeable human prolyl oligopeptidase inhibitors.
    Tarragó T; Masdeu C; Gómez E; Isambert N; Lavilla R; Giralt E
    ChemMedChem; 2008 Oct; 3(10):1558-65. PubMed ID: 18792035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-guided design of peptide-based tryptase inhibitors.
    McGrath ME; Sprengeler PA; Hirschbein B; Somoza JR; Lehoux I; Janc JW; Gjerstad E; Graupe M; Estiarte A; Venkataramani C; Liu Y; Yee R; Ho JD; Green MJ; Lee CS; Liu L; Tai V; Spencer J; Sperandio D; Katz BA
    Biochemistry; 2006 May; 45(19):5964-73. PubMed ID: 16681368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dicarboxylic acid azacycle l-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
    Jarho EM; Wallén EA; Christiaans JA; Forsberg MM; Venäläinen JI; Männistö PT; Gynther J; Poso A
    J Med Chem; 2005 Jul; 48(15):4772-82. PubMed ID: 16033257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 4-substituted benzylamine derivatives as beta-tryptase inhibitors.
    Miyazaki Y; Kato Y; Manabe T; Shimada H; Mizuno M; Egusa T; Ohkouchi M; Shiromizu I; Matsusue T; Yamamoto I
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2986-90. PubMed ID: 16540315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.